Literature DB >> 6430213

Paraproteins in the spinal fluid of patients with paraproteinemic polyneuropathies.

M C Dalakas, N M Papadopoulos.   

Abstract

High-resolution agarose gel electrophoresis, combined with immunofixation electrophoresis, was used to detect and identify immunoglobulins in the cerebrospinal fluid of six patients with paraproteinemic polyneuropathy. In four patients with serum IgM kappa monoclonal protein, we found a discrete band in the cerebrospinal fluid identified also as IgM kappa; one patient with serum IgG kappa had an IgG kappa cerebrospinal fluid band, and one patient with serum IgA kappa had an IgA kappa monoclonal band in the cerebrospinal fluid. The permeability of the blood-cerebrospinal fluid barrier was increased 3 to 10 times in all these patients. The findings indicate that in patients with paraproteinemic polyneuropathy, the increased permeability of the blood-cerebrospinal fluid barrier results in influx of serum proteins into the cerebrospinal fluid, including high-molecular-weight IgM. Because monoclonal IgM, unlike monoclonal IgG and IgA, is not found in the cerebrospinal fluid of neurologically intact patients, its presence in the cerebrospinal fluid of patients with paraproteinemias should lead the physician to suspect neurological involvement and can be of diagnostic value.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430213     DOI: 10.1002/ana.410150612

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

1.  Waldenstrom-associated anti-MAG paraprotein polyneuropathy with neurogenic tremor.

Authors:  Carlo Canepa
Journal:  BMJ Case Rep       Date:  2019-03-31

2.  Characterization of amyloid deposits in biopsies of 15 with "sporadic" (non-familial or plasma cell dyscrasia amyloid polyneuropathy.

Authors:  M C Dalakas; G Cunningham
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

Review 3.  The clinical use of cerebrospinal fluid studies in demyelinating neurological diseases.

Authors:  M G Harrington; P G Kennedy
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

4.  Pathogenesis and Treatment of Anti-MAG Neuropathy.

Authors:  Marinos C Dalakas
Journal:  Curr Treat Options Neurol       Date:  2010-03       Impact factor: 3.598

5.  Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome.

Authors:  Monique C Minnema; Eva Kimby; Shirley D'Sa; Luc-Matthieu Fornecker; Stéphanie Poulain; Tom J Snijders; Efstathios Kastritis; Stéphane Kremer; Aikaterini Fitsiori; Laurence Simon; Frédéric Davi; Michael Lunn; Jorge J Castillo; Christopher J Patterson; Magali Le Garff-Tavernier; Myrto Costopoulos; Véronique Leblond; Marie-José Kersten; Meletios A Dimopoulos; Steven P Treon
Journal:  Haematologica       Date:  2016-10-06       Impact factor: 9.941

6.  Demyelinating optic neuropathy with Miller-Fisher syndrome. The case for overlap syndromes with central and peripheral demyelination.

Authors:  P Toshniwal
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

Review 7.  Polyneuropathy in paraproteinaemia.

Authors:  C Meier
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

Review 8.  Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies.

Authors:  Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2018-01-15       Impact factor: 6.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.